Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 484 of 6351
-
Digital tool aims to boost emotional skills in middle schoolers
Prevention By invitation onlyEarly adolescence (ages 11-14) is a key developmental period repeatedly coupled with the onset of mental health problems. Middle schools provide a naturalistic setting in which to implement programming to prevent the development of more significant mental health problems. School-…
Sponsor: University of Oregon • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Ketamine combo may halt prolonged seizures faster
Disease control Recruiting nowThe goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
Phase 3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New shot aims to cure hepatitis b – early trial underway
Disease control Recruiting nowThis study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with Nucleos(t)ide Analogue (NAs).
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for leukemia patients: immunotherapy added to standard care
Disease control Not yet recruitingThe goal of this trial is to provide a protocol for treatment for adults with Ph-negative acute lymphoblastic leukemia (ALL) and to learn if this provides higher probability of survival than the previous one. The main question is to know if the incorporation of blinatumomab for B…
Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Shorter radiation for prostate cancer recurrence? new trial tests 2-Week option
Disease control Recruiting nowThis study is the first prospective, randomized phase III clinical trial designed to evaluate whether ultrahypofractionated radiotherapy is non-inferior to conventionally moderately hypofractionated radiotherapy in terms of efficacy, with acceptable toxicity, in patients who deve…
Phase 3 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Shingles vaccine protection tested over 6 years in 24,740 adults
Prevention Recruiting nowThis is a multicenter retrospective cohort study to evaluate the long-term effectiveness of the live attenuated herpes zoster vaccine within 6 years after vaccination. We plan to select 24,740 participants who were non-herpes zoster cases in the modified Full Analysis Set for Eff…
Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail may spare kidney removal in High-Risk bladder cancer patients
Disease control Recruiting nowThis Phase II clinical trial, titled "A Phase II Trial of Sequential Gemcitabine and Mitomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)," aims to evaluate the safety and effectiveness of a combination chemotherapy treatment for patients …
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New cell therapy trial targets Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis study, a single-center, open, single-dose clinical study, was designed to evaluate the safety and efficacy of IM96 CAR-T cells in treating patients with advanced adenocarcinoma of gastric/esophagogastric junction
Phase 1 • Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Simple breath test could revolutionize lung cancer screening
Diagnosis Recruiting nowLung cancer remains the leading cause of cancer-related death in the UK, with over 35,000 deaths annually and most cases diagnosed at a late stage. Current screening programmes using low-dose CT scans target only high-risk individuals, missing around 30% of lung cancer cases, inc…
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New drug nipocalimab aims to tame lupus in major trial
Disease control Recruiting nowThe purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redne…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Immunotherapy combo tested against untreatable liver cancer
Disease control Recruiting nowThis study looks at how a combination of two medicines, nivolumab and ipilimumab, is used to treat people with advanced liver cancer that cannot be removed by surgery. The study will follow adults receiving this treatment in routine medical care in Japan to understand how safe it…
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug targets liver fat and weight in obesity trial
Disease control Recruiting nowThe main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or overweight and elevated liver fat content, when administered in conjunction with r…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis study is a multicenter, randomized, controlled phase III clinical trial aiming to investigate the efficacy and safety of Becotatug Vedotin induction therapy followed by concurrent chemoradiotherapy (CCRT) combined with neoadjuvant and adjuvant sintilimab, versus gemcitabine …
Phase 3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New heart valve procedure could offer safer alternative to Open-Heart surgery for seniors
Disease control Recruiting nowThe overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Radioactive antibody targets tough prostate cancer in early trial
Disease control Recruiting nowA Phase 1/2a Study to Evaluate the Safety, Tolerability, Whole-Body Distribution, and Preliminary Clinical Activity of 161Tb-RAD402, a Radiolabeled Anti-KLK3 Monoclonal Antibody Targeting Free Prostate-Specific Antigen, in Participants with Castration-Resistant Prostate Cancer (C…
Phase 1/2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to reactivate Cancer-Fighting genes in solid tumors
Disease control Recruiting nowRational, objective and design: Some cancer-protecting genes are inactivated when the EZH2 enzyme is too active or the SWI/SNF complex is less active. The EZH1/2 enzymes and the SWI/SNFs complex play opposing roles in gene expression: we hypothesize that valemetostat, an inhibito…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for hard-to-treat colon cancer? phase 3 trial launches
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo therapy offers hope for tough bone cancer
Disease control Recruiting nowIn advanced osteosarcoma where traditional chemotherapy has failed, the multi-targeted tyrosine kinase inhibitor apatinib has become a mainstream systemic treatment option in China. However, for patients with a high tumor burden or extra-pulmonary lesions, these drugs are prone t…
Phase 1/2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control By invitation onlyThis is an open -label phase I /IIa study designed to evaluate the safety and efficacy of IMC001 in patients with advanced epithelial solid tumors. The study comprises two parts: a phase I dose-escalation phase and a phase IIa phase to further explore and validate efficacy .In th…
Phase 1/2 • Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a Fasting-Mimicking diet boost breast cancer treatment?
Disease control Recruiting nowThe primary objective of this study is to investigate the efficacy and safety of a fasting-mimicking diet (FMD) intervention combined with standard neoadjuvant chemoimmunotherapy in early-stage or locally advanced triple-negative breast cancer (TNBC).
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC